Identification and Analysis of the Blood lncRNA Signature for Liver Cirrhosis and Hepatocellular Carcinoma
As one of the most common malignant tumors, hepatocellular carcinoma (HCC) is the fifth major cause of cancer-associated mortality worldwide. In 90% of cases, HCC develops in the context of liver cirrhosis and chronic hepatitis B virus (HBV) infection is an important etiology for cirrhosis and HCC,...
Main Authors: | Qi Xia, Zheyue Shu, Ting Ye, Min Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-12-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fgene.2020.595699/full |
Similar Items
-
Corrigendum: Identification and Analysis of the Blood lncRNA Signature for Liver Cirrhosis and Hepatocellular Carcinoma
by: Qi Xia, et al.
Published: (2021-07-01) -
Identification of a novel four-lncRNA signature as a prognostic indicator in cirrhotic hepatocellular carcinoma
by: Linkun Ma, et al.
Published: (2019-08-01) -
Development and Validation of an Immune-Related lncRNA Signature for Predicting the Prognosis of Hepatocellular Carcinoma
by: Weihao Kong, et al.
Published: (2020-09-01) -
PHAROH lncRNA regulates Myc translation in hepatocellular carcinoma via sequestering TIAR
by: Allen T Yu, et al.
Published: (2021-05-01) -
Identification and Validation of Hypoxia-Related lncRNA Signature as a Prognostic Model for Hepatocellular Carcinoma
by: Chenghui Zhou, et al.
Published: (2021-09-01)